Company Name: |
Sigma-Aldrich
|
Tel: |
021-61415566 800-8193336 |
Email: |
orderCN@merckgroup.com |
Products Intro: |
Product Name:VPC 12249 (S) CAS:799268-73-8 Purity:(S)-phosphoric acid mono-[3-(4-benzyloxy-phenyl)-2-octadec-9 Package:1MG Remarks:857341P-1MG
|
Company Name: |
Codow Chemical Co.,Ltd.
|
Tel: |
18620099427 |
Email: |
amy@howeipharm.com |
Products Intro: |
Product Name:(S)-phosphoric acid mono-[3-(4-benzyloxy-phenyl)-2-octadec-9-enoylamino-propyl] ester (ammonium salt) CAS:799268-73-8 Purity:>99% Package:1MG;2.5MG;5MG;10MG
|
|
| (S)-phosphoric acid Mono-[3-(4-benzyloxy-phenyl)-2-octadec-9-enoylaMino-propyl] ester (aMMoniuM salt) Basic information |
| (S)-phosphoric acid Mono-[3-(4-benzyloxy-phenyl)-2-octadec-9-enoylaMino-propyl] ester (aMMoniuM salt) Chemical Properties |
| (S)-phosphoric acid Mono-[3-(4-benzyloxy-phenyl)-2-octadec-9-enoylaMino-propyl] ester (aMMoniuM salt) Usage And Synthesis |
Uses | VPC 12249 has been used as lysophosphatidic acid (LPA)1/3 receptor antagonist in various experimental studies. | General Description | VPC 12249 is an N-acyl (oleoyl) serine phosphate-based compound. | Biochem/physiol Actions | Lysophosphatidic acids (LPAs) are bioactive lipid mediators. It interacts with at least six specific LPA receptors (LPA1-6) to mediate extracellular signaling pathway. LPA and its receptors (LPA1-3) are implicated in the pathogenesis of radiation pneumonitis (RP). VPC 12249 (S) inhibits the binding ofLPA to LPA1 and LPA3 receptor. |
| (S)-phosphoric acid Mono-[3-(4-benzyloxy-phenyl)-2-octadec-9-enoylaMino-propyl] ester (aMMoniuM salt) Preparation Products And Raw materials |
|